| Product NDC: | 0409-0201 |
| Proprietary Name: | Docetaxel |
| Non Proprietary Name: | DOCETAXEL ANHYDROUS |
| Active Ingredient(s): | 10 mg/mL & nbsp; DOCETAXEL ANHYDROUS |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-0201 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022234 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110308 |
| Package NDC: | 0409-0201-20 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-0201-20) > 16 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 0409-0201-20 |
| Proprietary Name | Docetaxel |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-0201-20) > 16 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0409-0201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOCETAXEL ANHYDROUS |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110308 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | DOCETAXEL ANHYDROUS |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |